Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Harrabi SB"'
Autor:
Seravalli E; Department of Radiation Oncology, University Medical Center Utrecht, 3508 GA, The Netherlands., Kroon PS; Department of Radiation Oncology, University Medical Center Utrecht, 3508 GA, The Netherlands., Bolle S; Department of Radiation Oncology, Gustave Roussy Campus, Villejuif 94 800, France., Dunlea C; Department of Oncology, University College London Hospitals NHS Foundation Trust, London NW1 2PB, United Kingdom., Harrabi SB; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg 69120, Germany., Laprie A; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse 31100, France., Lassen-Ramshad Y; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus DK-8200, Denmark., Whitfield G; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Manchester M20 4BX, United Kingdom., Janssens GO; Department of Radiation Oncology, University Medical Center Utrecht, 3508 GA, The Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht 3582CS, The Netherlands.
Publikováno v:
The British journal of radiology [Br J Radiol] 2024 May 07; Vol. 97 (1157), pp. 1044-1049.
Autor:
Eekers DBP; Department of Radiation Oncology (Maastro), Maastricht University Medical Center, GROW-School for Oncology and Reproduction, Maastricht, The Netherlands., Zegers CML; Department of Radiation Oncology (Maastro), Maastricht University Medical Center, GROW-School for Oncology and Reproduction, Maastricht, The Netherlands., Ahmed KA; Departments of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Amelio D; Trento Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy., Gupta T; Department of Radiation Oncology, ACTREC/TMH, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India., Harrabi SB; Department of Radiation Oncology, Heidelberg Ion Beam Therapy Center (HIT), University Hospital Heidelberg, Heidelberg, Germany., Kazda T; Department of Radiation Oncology, Faculty of Medicine, Masaryk University and Masaryk Memorial Cancer Institute, Brno, Czech Republic., Scartoni D; Trento Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy., Seidel C; Comprehensive Cancer Center Central Germany, Leipzig, Germany.; Department of Radiation Oncology, University of Leipzig Medical Center, Leipzig, Germany., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.; IRCCS Neuromed, Pozzilli IS, Italy.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Apr 29; Vol. 11 (4), pp. 369-382. Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024).
Autor:
Weusthof K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany. Electronic address: katharina.weusthof@med.uni-heidelberg.de., Held T; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Lang K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Rachel ZE; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany., Harrabi SB; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Plath K; Departments of Otorhinolaryngology and., Freudlsperger C; Oral and Maxillofacial Surgery, University Hospital Heidelberg (UKHD), Heidelberg, Germany., Herfarth K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Debus J; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Haberer T; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany., Münter M; Department of Radiation Oncology, Klinikum Stuttgart, Stuttgart, Germany., Jensen AD; Department of Radiation Oncology, Klinikum Fulda, Fulda, Germany., Adeberg S; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; Department of Radiotherapy and Radiation Oncology and; Marburg Ion-Beam Therapy Center (MIT), Department of Radiotherapy and Radiation Oncology, Marburg University Hospital, Marburg, Germany; UCT - Universitäres Centrum für Tumorerkrankungen Frankfurt-Marburg.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1563-1574. Date of Electronic Publication: 2023 Oct 20.
Autor:
Forster T; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Köhler C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Dorn M; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Häfner MF; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Arians N; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Schlampp I; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Lang K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany., Heinrich V; Department of Radiation Oncology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany., Weidner N; Department of Radiation Oncology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany., Hüsing J; Division of Biostatistics, Coordination Centre for Clinical Trials, University of Heidelberg, Heidelberg, Germany., Wallwiener M; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Golatta M; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Hennigs A; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Heil J; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Hof H; Strahlentherapie Rhein-Pfalz, Neustadt, Germany., Krug D; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany; Department of Radiation Oncology, University Hospital Schleswig Holstein, Kiel, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center, Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium, partner site Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. Electronic address: juliane.hoerner-rieber@med.uni-heidelberg.de.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Nov 15; Vol. 117 (4), pp. 857-868. Date of Electronic Publication: 2023 May 26.
Autor:
Friedrich C; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany., Boekhoff S; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany., Bischoff M; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Essen, Germany., Beckhaus J; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany., Sowithayasakul P; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany.; Department of Pediatrics, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand., Calaminus G; Department of Pediatric Hematology/Oncology, University of Bonn Medical Center, Bonn, Germany., Eveslage M; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Valentini C; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Bison B; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Krause M; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden with German Cancer Research Center (DKFZ), University Hospital and Faculty of Medicine Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ) Heidelberg, Dresden, Germany., Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ) and German Cancer Consortium (DKTK), Essen, Germany., Müller HL; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Oct 27; Vol. 13, pp. 1180993. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2023).
Autor:
Held T; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. thomas.held@med.uni-heidelberg.de.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany. thomas.held@med.uni-heidelberg.de.; National Center for Tumor diseases (NCT), Heidelberg, Germany. thomas.held@med.uni-heidelberg.de., Franke H; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany., Lang K; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Regnery S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Weusthof K; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Bauer L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Plath K; Department of Otorhinolaryngology, Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany., Dyckhoff G; Department of Otorhinolaryngology, Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany., Plinkert PK; Department of Otorhinolaryngology, Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Adeberg S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Radiation oncology (London, England) [Radiat Oncol] 2022 Dec 05; Vol. 17 (1), pp. 199. Date of Electronic Publication: 2022 Dec 05.
Autor:
Wickert R; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Tessonnier T; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Deng M; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Adeberg S; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Seidensaal K; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Hoeltgen L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Nov 28; Vol. 14 (23). Date of Electronic Publication: 2022 Nov 28.
Autor:
Seidensaal K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany., Dostal M; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Liermann J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany., Adeberg S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany., Schmid MP; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Freudlsperger C; Department of Oral and Maxillofacial Surgery, Heidelberg University Hospital, Heidelberg, Germany., Hoffmann J; Department of Oral and Maxillofacial Surgery, Heidelberg University Hospital, Heidelberg, Germany., Hompland I; Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Sep 23; Vol. 12, pp. 927399. Date of Electronic Publication: 2022 Sep 23 (Print Publication: 2022).
Autor:
Seidensaal K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Sailer J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Harrabi SB; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., von Gehlen J; Department of Business Psychology, Fachhochschule für Ökonomie und Management (FOM), Munich, Germany., Seidensaal I; Rehabilitation facility for mentally ill and disabled (ERPEKA), Nuremberg, Germany., Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Bernhardt D; Department of Radiation Oncology, Klinikum rechts der Isar, Munich, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Aug 05; Vol. 12, pp. 677181. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Autor:
Adeberg S; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany. Sebastian.adeberg@med.uni-heidelberg.de.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Sebastian.adeberg@med.uni-heidelberg.de.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Sebastian.adeberg@med.uni-heidelberg.de.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Sebastian.adeberg@med.uni-heidelberg.de.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. Sebastian.adeberg@med.uni-heidelberg.de., Knoll M; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Koelsche C; Department of Neuropathology, University Hospital of Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Bernhardt D; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, TUM, Ismaninger Str. 22, 81675, Munich, Germany., Schrimpf D; Department of Neuropathology, University Hospital of Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Sahm F; Department of Neuropathology, University Hospital of Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., König L; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Harrabi SB; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hörner-Rieber J; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Verma V; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center Houston, Houston, TX, USA., Bewerunge-Hudler M; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Unterberg A; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Sturm D; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Angelika Lautenschläger Children's Hospital, University Medical Center for Children and Adolescents, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany., Jungk C; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Herold-Mende C; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Wick W; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Neurooncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., von Deimling A; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Neuropathology, University Hospital of Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Debus J; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Rieken S; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Abdollahi A; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), UKHD and DKFZ, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2022 Jul; Vol. 144 (1), pp. 129-142. Date of Electronic Publication: 2022 Jun 04.